Biopharma major AstraZeneca has entered into an agreement with the Pune-based Serum Institute of India (SII), among other world-wide vaccine manufacturers, to produce the vaccine currently under tria…
Read More

WP2Social Auto Publish Powered By : XYZScripts.com
Scroll Up